As per Business Intelligence Insights (BII) study, the global Electronic Clinical Outcome Assessment (eCOA) Solutions Market attained revenue growth of USD 1,182.5 million in 2021 and it is projected to reach around USD 3,349.5 million by 2030, growing at a 13.9% CAGR.
Market Dynamics :
Increased regulatory compliance among industrial researchers, growing public-private investments in clinical research, a growing need for improved data standardization and collection aimed at early regulatory approval, and an expansion of the end-user base across major countries are the major factors driving their market expansion. A system capable of monitoring mental state, patient symptoms, and illness prognosis are referred to as an electronic clinical outcome assessment (eCOA). Electronic diaries and electronic Patient Reported Outcomes are two main components of eCOA platforms (ePRO). These components serve as ePRO's support systems. Compliance rates are extremely high in all types of clinical outcome assessment system applications, facilitating research procedures.
The market is expected to rise due to an increase in clinical trials, the need to improve compliance, efficiently capture and manage clinical information, the need to minimize costs, and an increase in R&D activities. The increasing use of eCOA by medical research experts is propelling market expansion. As the number of research projects grows, so does the demand for a centralized data gathering system that may help improve patient participation. This is expected to drive market demand throughout the forecast period. During the pandemic, the use of electronic patient-reported outcomes (ePROs) has developed as a useful method for collecting and sharing essential trial data, as well as using additional embedded tools such as alerts and reminders to weave the study into patients' daily lives. Technological innovations such as Alexa-style tools, reward features, and gamification are expected to improve eCOA solutions in the future, driving the market growth. The increasing pressure on pharmaceutical companies to reduce total costs for new drug development procedures has resulted in a shift away from paper-based procedures and toward computerized data capture.
Revenue-generating Segment Highlights :
By Delivery Mode
On-premise Web & Cloud-based
By End-User
Hospitals/Healthcare providers CROs Pharmaceutical and Biotechnology Firms Medical Device Companies Others
By Region
North Americao U.S.
o Canada
Europeo Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
Asia Pacifico China
o India
o Japan
o Rest of Asia Pacific
Latin Americao Brazil
o Mexico
o Rest of Latin America
Middle East and Africao UAE
o South Africa
o Rest of Middle East and Africa (MEA)
List of key players :
IBM IQVIA Inc. Medidata SolutionsInc. Clario; ArisGlobal Signant Health TransPerfect Cloudbyz Climedo Health GmbH ClinCapture
Key Highlights of the Report :
In 2021, the web and cloud-based categories supplied the most revenue to the market by delivery mode. This is due to the accompanying advantages of its use. Some of the primary features provided by these systems include remote access to the patient's health information and information sharing to restrict potential data misuse or address problems at a critical moment of study. Other advantages include data centralization, scalability, cost savings, and uptime consistency. Contract Research Organizations (CROs) had the highest revenue share in 2021 and are likely to increase significantly in the near future as major biopharmaceutical and medical device companies outsource clinical research management. For example, IQVIA eCOA enables real-time patient data collecting in real-world investigations and clinical research. During COVID-19, the technology was used in various trials to capture real-time data in a cost-effective and remote manner. In 2021, North America is expected to be the largest regional market. The existence of technologically advanced research institutions, medical device manufacturers, universities, and hospitals, along with better healthcare facilities, is projected to stimulate new drug development efforts in the next years. Because of higher levels of adoption of eClinical solutions, the United States will account for the greatest market share in North America in 2021. Initiatives aimed at increasing the use of eClinical platforms by major end-users are expected to increase usage in the future years. The report contains qualitative and quantitative research on the global Electronic Clinical Outcome Assessment (eCOA) Solutions Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.
Read our strategic analysis : https://www.businessintelligence-insights.com/press-release/44/electronic-clinical-outcome-assessment-ecoa-solutions-market
0
Sign in to leave a comment.